Status:
COMPLETED
ILM Inverted Flap Size in Macular Hole
Lead Sponsor:
Mansoura University
Conditions:
Idiopathic Macular Hole
Eligibility:
All Genders
Phase:
NA
Brief Summary
In the current study, the investigators described the results of a randomized, comparative clinical trial that was conducted to study the impact of the size of internal limiting membrane (ILM) inverte...
Detailed Description
A prospective randomized comparative study included patients with idiopathic macular hole (MH) attending outpatient clinic.Eligible eyes were divided into 2 groups based on the narrowest diameter of t...
Eligibility Criteria
Inclusion
- Eyes with stage 4 idiopathic MHs with a diameter \>250µm on spectral domain optical coherence tomography (SD-OCT)
Exclusion
- traumatic MH
- myopic MHs,
- MH secondary to retinal detachment,
- long-standing MH\> 12 months
- previous retinal surgeries
- high myopia with an axial length \> 26.0 mm
- other ocular pathologies interfering with the interpretation of the OCT reports.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2020
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04683276
Start Date
February 1 2019
End Date
October 1 2020
Last Update
December 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic center
Al Mansurah, Dakahelia, Egypt, 35516